Profiel
Martin Steiner is the founder of ImVisioN Therapeutics AG, which was founded in 2008.
He held the position of Director, Chief Executive & Financial Officer from 2011 to 2014.
Dr. Steiner is currently the President, Secretary, Treasurer & Director at ImVision Therapeutics, Inc. and Co-Managing Director at SYNIMMUNE GmbH since 2016.
In the past, he was the Chief Executive Officer at Apovia AG from 1997 to 2004 and Director-Business Development at Smithkline Beecham Biologicals Immunotherapeutics in 1997.
Dr. Steiner was also the Chief Executive & Financial Officer at ImVisioN GmbH.
Dr. Steiner holds an MBA from the University of Michigan and a doctorate from the University of Vienna.
Actieve functies van Martin Steiner
| Bedrijven | Functie | Begin |
|---|---|---|
ImVision Therapeutics, Inc.
ImVision Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops proprietary technology for the delivery of immunotherapeutics in the treatment of allergies | President | - |
SYNIMMUNE GmbH
SYNIMMUNE GmbH Miscellaneous Commercial ServicesCommercial Services Operates as a bio technology company that develops antibodies | Algemeen Directeur | 01-03-2016 |
Eerdere bekende functies van Martin Steiner
| Bedrijven | Functie | Einde |
|---|---|---|
ImVisioN Therapeutics AG
ImVisioN Therapeutics AG Miscellaneous Commercial ServicesCommercial Services Operates as a holding company with interest in providing immunotherapy | Algemeen Directeur | 13-02-2014 |
Apovia AG | President | 01-01-2004 |
Smithkline Beecham Biologicals Immunotherapeutics | Corporate Officer/Principal | 01-01-1997 |
ImVisioN GmbH
ImVisioN GmbH Miscellaneous Commercial ServicesCommercial Services Provides research in intralymphatic immunotherapy | Algemeen Directeur | - |
Opleiding van Martin Steiner
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
ImVision Therapeutics, Inc.
ImVision Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops proprietary technology for the delivery of immunotherapeutics in the treatment of allergies | Health Technology |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Vienna
University of Vienna Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ImVisioN GmbH
ImVisioN GmbH Miscellaneous Commercial ServicesCommercial Services Provides research in intralymphatic immunotherapy | Commercial Services |
Apovia AG | |
ImVisioN Therapeutics AG
ImVisioN Therapeutics AG Miscellaneous Commercial ServicesCommercial Services Operates as a holding company with interest in providing immunotherapy | Commercial Services |
Smithkline Beecham Biologicals Immunotherapeutics | |
SYNIMMUNE GmbH
SYNIMMUNE GmbH Miscellaneous Commercial ServicesCommercial Services Operates as a bio technology company that develops antibodies | Commercial Services |
















